Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Topical Drugs CDMO Market
Topical Drugs CDMO Market Size
- Report ID: GMI9137
- Published Date: Oct 2024
- Report Format: PDF
Topical Drugs CDMO Market Size
The global topical drugs CDMO market was valued at USD 43.7 billion in 2023 and is estimated to grow at a CAGR of over 10.5% from 2024 to 2032. The growth of the market is primarily driven by an increasing focus on non-invasive drug delivery systems.
The topical formulations such as creams, gels, ointments, and transdermal patches are gaining popularity as patients and healthcare providers seek safer and more convenient alternatives to oral and injectable medications. Furthermore, pharmaceutical companies are increasingly outsourcing the development and production of these specialized topical drugs to CDMOs that possess expertise, advanced manufacturing capabilities, and regulatory knowledge to meet these complex demands.
CDMOs are investing in facilities and expanding their services to include formulation development, clinical trial support, and commercial production for personalized topical treatments. For instance, in September 2024, Blue Wolf Capital Partners LLC expanded its pharmaceutical presence by acquiring seven European manufacturing facilities from Recipharm in Sweden, France, and Spain, which specialize in oral solid, semi-solid, and liquid dosage forms. Additionally, Blue Wolf agreed to acquire Synerlab, a French CDMO with six facilities. These acquisitions have enhanced Blue Wolf's CDMO capabilities, regulatory expertise, and geographical reach, positioning them as a key player in the European pharmaceutical market. Thus, the aforementioned trends collectively contribute to fostering market growth in the coming years.
Topical drugs CDMO refers to service providers that offer specialized outsourcing services for the development and manufacturing of topical drug products. Topical drugs are medications designed to be applied directly to the skin or mucous membranes for localized or systemic effects. CDMOs in this area provide various services to pharmaceutical, biotechnology, and specialty pharma companies, assisting them in bringing topical drug products from the research and development stage to commercialization.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Topical Drugs CDMO Market Size in 2023: | USD 43.7 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 10.5% |
| 2032 Value Projection: | USD 105.9 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 140 |
| Tables, Charts & Figures: | 171 |
| Segments covered: | Product Type, Therapeutic Area, Service Type, End Use and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Topical Drugs CDMO Market Scope
